Particle.news

Download on the App Store

Serena Williams Reveals GLP‑1 Use, Becomes Ambassador for Ro’s Weight‑Loss Campaign

She reports a 31‑pound loss since April with no side effects, aiming to destigmatize medically guided treatment.

Serena Williams en una entrevista con "TODAY" reveló el secreto de su pérdida de peso.
Image
Serena Williams confesó que usa Ozempic para adelgazar y generó un aluvión de críticas.

Overview

  • Williams says she began a GLP‑1 regimen in April 2025 and has lost about 13–14 kilograms so far.
  • Ro named her a multiyear ambassador, with a campaign launching at the US Open, in Times Square, and across New York’s subway.
  • She cites a family history of diabetes and lingering knee problems after pregnancy as the reasons for pursuing medication.
  • Ro says Williams was already a patient, and her husband Alexis Ohanian is an investor and board member at the company.
  • Reports note GLP‑1 drugs are approved for certain obesity cases, can cause gastrointestinal side effects, often require continued use, and surging demand has fueled concerns about access for people with diabetes.